TD Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $673K | Sell |
|
|||||
|
2023
Q1 | $806K | Sell |
|
|||||
|
2022
Q4 | $491K | Buy |
|
|||||
|
2022
Q3 | $299K | Hold |
|
|||||
|
2022
Q2 | $363K | Sell |
|
|||||
|
2022
Q1 | $441K | Sell |
|
|||||
|
2021
Q4 | $932K | Buy |
|
|||||
|
2021
Q3 | $2.67M | Sell |
|
|||||
|
2021
Q2 | $3.35M | Sell |
|
|||||
|
2021
Q1 | $2.95M | Buy |
|
|||||
|
2020
Q4 | $3.32M | Buy |
|
|||||
|
2020
Q3 | $2.05M | Buy |
|
|||||
|
2020
Q2 | $3.12M | Sell |
|
|||||
|
2020
Q1 | $3.04M | Sell |
|
|||||
|
2019
Q4 | $6.77M | Buy |
|
|||||
|
2019
Q3 | $2.2M | Buy |
|
|||||
|
2019
Q2 | $1.86M | Buy |
|
|||||
|
2019
Q1 | $1.35M | Buy |
|
|||||
|
2018
Q4 | $876K | Buy |
|
|||||
|
2018
Q3 | $1.25M | Buy |
|